I can't see the SP dropping on mining license approval. Kodal is the most hotly anticipated Lithium plays out there at the moment. Would certainly expect to see a return to .50 on approval.
Also sold. Agree with you regarding Tony, this sort of cowboy ‘analysis’ is very much the crux of what is wrong with forums today, and should be absolutely disregarded.
Working better on late stage patients yes, but nonetheless surely results can show a preventive. Very confused here, how can a drug show lesser effects In earlier stages if inevitably said patient may end up in a hospital setting.